United States $57 Billion Private Equity Firm Clayton Dubilier & Rice (CD&R) in Talks to Buy 50% of France Pharmaceutical Giant Sanofi Consumer Healthcare Business Opella for $16.4 Billion
12th October 2024 | Hong Kong
United States private equity firm Clayton Dubilier & Rice (CD&R) with $57 billion AUM is in talks to buy 50% of France pharmaceutical giant Sanofi consumer healthcare business Opella for $16.4 billion.
“ United States $57 Billion Private Equity Firm Clayton Dubilier & Rice (CD&R) in Talks to Buy 50% of France Pharmaceutical Giant Sanofi Consumer Healthcare Business Opella for $16.4 Billion “
United States $57 Billion Private Equity Firm Clayton Dubilier & Rice (CD&R) in Talks to Buy 50% of France Pharmaceutical Giant Sanofi Consumer Healthcare Business Opella for $16.4 Billion
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit